Genetics in the Progression of Nephropathies
Recruiting
Observational Study
AKI
CKD
Ckd-Mbd
CKD (Chronic Kidney Disease) Stage 5D
ADPKD
Hypertension
Hematologic Malignancy
Bone Marrow Transplant Complications
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 10,000 (estimated)
- Sponsor
- Ospedale San Raffaele · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study evaluates the role of genetic in the development and progression of different nephropaties with particular attention to:
* AKI
* CKD
* Hypertension
* ADPKD
* CKD-MBD
* Patients with decompensated heart failure undergoing either medical or surgery therapy
* Patients with hematologic cancer exposed to chemotherapeutic agents or undergoing allogeneic bone marrow transplantation
* glomerul…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
. presence of specific renal disease
Exclusion Criteria:
* to be evaluated in the different sub-protocols
Contacts